about
Hepatocellular carcinoma: Review of disease and tumor biomarkersGuide for diagnosis and treatment of hepatocellular carcinomaControlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs.Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinomaDevelopment of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinomaPercutaneous ablation of hepatic tumors.A review on laboratory liver function tests.GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis.Aptamer-based Sandwich Assay and its Clinical Outlooks for Detecting Lipocalin-2 in Hepatocellular Carcinoma (HCC).The promise of metabolic phenotyping in gastroenterology and hepatology.Hepatocellular carcinoma: focus on different aspects of managementOsteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma.Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis.Liver transplantation for small hepatocellular carcinoma.Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.Hepatocellular carcinoma: diagnostics and screening.Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis.Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods.Tumour-associated antigens and their anti-cancer applications.Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control Study.Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma.Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.Clinical utility of a simple primary culture method in hepatocellular carcinoma patients.Diagnosis of hepatoma using grayscale and Doppler ultrasound in patients with chronic liver disease.Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid Adenocarcinoma: A Case Report.The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma.Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma.Is the American Association for the Study of Liver Diseases recommendation for hepatocellular carcinoma screening a cul-de-sac?Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
P2860
Q26750796-03F57286-C060-46F5-9B06-626059980F7FQ28084003-D6334700-6979-45D5-B9AF-D426356040D3Q30226462-8D41DC23-6155-4844-B9AE-E9920D2F472FQ33625984-C3D9A78A-1B33-4CFB-A3A9-6C4536C22442Q33753952-8771DE82-5146-4E43-B962-D1B9418E47CDQ34253356-7378DBC2-1512-4245-B48F-B0358DF41611Q34321014-79AAFCC7-5B34-4D45-A469-5D9A6FACC3CDQ35114636-D3D216DA-992E-45C0-A06C-787EBD050D67Q35422169-B1EE34AE-9D4A-47DA-A95F-86B2FFD86232Q35577934-BB9EA48E-05D1-4443-A13B-DB7DC05EE765Q35678916-47EA6E39-FBDC-488B-BB23-C8234211E297Q35701279-0787C873-042E-4CEF-8C9E-FE04763A085DQ35986436-1F907C99-F615-43DD-AF06-23C377ABFA6BQ36198665-AC936FFD-5D35-4C65-83D4-A7FF2975CF74Q36319775-977C9430-306E-4251-AEB8-F126DDE28841Q37206392-4223151D-4CED-4D79-B6EE-0EF6DBBAD389Q37338973-699DBDC9-3C4A-4B4D-A417-6E88D16584C8Q37360177-771E6F3C-F36E-4DBD-9799-2947241155C5Q37477526-D31D44D8-9CAA-41F0-9B56-59ED296B3384Q37512658-A754DAB7-BD5D-4730-9ADF-204A697EADACQ37578500-70B5894B-410E-4A45-A39C-0CFC2DC16459Q37813192-2FE0C388-EBE2-44EA-B3D3-A3D6EC2FE843Q38092003-519E4DE8-28EB-424D-81B7-DAAEE58C73B1Q38213800-DC748664-8C9E-4E85-86D5-3B307C9E5A78Q38217009-1FF0BDBA-67AB-4E3C-87D4-F7A77EEC8651Q38725552-B6F09A01-4539-47AF-855C-7655157CE939Q38888032-93821634-2927-4BBE-BCD0-54DB6CE0900EQ39042825-7C283DC5-AB00-4E57-8CF8-4991DA28C7A5Q39091849-94D15332-79AA-4384-A8CE-A6DBA3D18FDCQ39149428-7FF25388-D0DF-49D8-B86B-BBBE9DA0398AQ39213771-16DBCB80-3A24-4090-AE82-5DAF8E591FCEQ39354326-D9C0125F-022D-429E-99FB-1B201B16524AQ40300595-295F7D11-2989-4B56-AE86-78F003F7951AQ40707324-097E68BE-1604-43E0-B19B-EDFF2C0C8CB6Q41742112-F6E5CAD0-64B4-4111-A6FE-35B100E2F12EQ42177750-147EA517-E421-4052-BEDD-53CAF7C5C014Q42268453-93BFDE33-95F2-47DB-9BD4-3CD8834266D7Q42279286-A23D427B-B972-476A-8F6D-3AC373A051C2Q43142658-08379CB6-D502-4C93-B4FE-67B5A42E0BE4Q44088955-720896CF-8E02-4555-AACC-24E335FC9EE9
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Diagnosis of hepatocellular carcinoma.
@ast
Diagnosis of hepatocellular carcinoma.
@en
type
label
Diagnosis of hepatocellular carcinoma.
@ast
Diagnosis of hepatocellular carcinoma.
@en
prefLabel
Diagnosis of hepatocellular carcinoma.
@ast
Diagnosis of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Diagnosis of hepatocellular carcinoma
@en
P2093
Edward L S Leen
Shahid A Khan
Simon D Taylor-Robinson
P2860
P304
P356
10.3748/WJG.15.1301
P407
P577
2009-03-01T00:00:00Z